Newsroom Careers Contact Us

Research and Development

Global R&D Centre

R&D is the heart of fulfilling Novugen's purpose and our main drive towards innovation. Located in the heart of Southeast Asia, our global R&D centre is based in Malaysia with highly experienced scientists. We focus on difficult to develop, technology-intensive products including complex generics conforming to USFDA standards.

Our Research & Development
R&D centre spreads across

40,000 sq. ft.

Highly qualified of over

200 scientists

Novugen Pharma is the first in ASEAN to develop products for US & EU markets

R&D Platforms

We have full capabilities to handle development services for a variety of dosage forms including:

Tablets, capsules and powders

Pellets and beads

Liquids, solutions, suspensions and emulsions

Soft Gel capsules

Parental Dosage Forms (Liquid and Lyophilized powders)

Granules for reconstitution

Drug in capsule/vial for clinical trials

Other Novel dosage forms(e.g MUPS, OCAS, DDR , etc.)


R&D Commitment

Novugen invests and re-invests in advanced technologies and highly experienced scientists to target difficult to develop and technology intensive products. Our advanced analytical lab and high-containment research centre in Malaysia for oncology and other therapeutic areas, support solid state characterisation for API & Finished Products to establish sameness with the brand product. This enables us to pass all bioequivalence studies from EU and USFDA approved Clinical Research Organizations (CRO’s).